drugset / Trial / NCT04200417

Chemoembolization for Lung Tumors

NCT04200417

Phase 1 Completed 10 enrolled Memorial Sloan Kettering Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

This study is being done to determine if it is safe to perform lung chemoembolization and if the lung chemoembolization procedure can successfully deliver chemotherapy to lung tumors.

Timeline

Start
2019-12-13
Primary completion
2022-04-19
Completion
2022-04-19

Drugs

EvaluationDrugModalityDoseRoute
Background Embospheres Unknown Other
Background Mitomycin C Other / unclassified 5 mg/m2 Other
Background lipiodol Unknown 2 mg/ml Other